A C1qTNF3 collagen domain fusion chaperones diverse secreted proteins and anti-Ab scFvs: Applications for gene therapies
RNA-seq (gene expression) · mouse · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 12 samples: 3 × PBS, F vs 3 × collagen domain, M vs 3 × collagen domain, F vs 3 × PBS, MGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- A C1qTNF3 collagen domain fusion chaperones diverse secreted proteins and anti-Aβ scFvs: Applications for gene therapiesMolecular therapy. Methods & clinical development · 2023
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE308665_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1331846 and SRA study SRP622776. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9250123 PBS, F-1 PBS, F
- GSM9250124 collagen domain, M-3 collagen domain, M
- GSM9250125 collagen domain, F-1 collagen domain, F
- GSM9250126 collagen domain, M-2 collagen domain, M
- GSM9250127 collagen domain, F-3 collagen domain, F
- GSM9250128 PBS, M-1 PBS, M
- GSM9250129 PBS, M 2 PBS, M
- GSM9250130 PBS, F-2 PBS, F
- GSM9250131 PBS, F-3 PBS, F
- GSM9250132 collagen domain, F-2 collagen domain, F
- GSM9250133 PBS, M-3 PBS, M
- GSM9250134 collagen domain, M-1 collagen domain, M
- GSE298799 Deconstructing the Intercellular Interactome in Vascular Dementia with Focal Ischemia for Therapeutic Applications 77 samples shares applications
- GSE288074 Transplant immunosuppressant therapies induce unique functional changes in and re-shape gut immune homeostasis 30 samples shares therapies
- GSE224091 Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer 26 samples shares therapies
- GSE293295 Discovery of BMS-986408, a First-In-Class Dual DGK⍺ and DGK Inhibitor That Unleashes PD-1 Checkpoint and CAR-T Cell Immunotherapies 20 samples shares therapies
- GSE288054 Protective effects of two different chaperones demonstrated in a mouse model of sporadic AD 20 samples shares chaperones
- GSE248058 Stroma reprogramming by FAK synergizes with MAPK inhibition and renders PDAC responsive to cytotoxic- and immuno-therapies II 18 samples shares therapies
- GSE224389 Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Mouse) 18 samples shares therapies
- GSE284107 Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib or belumosudil in murine sclerodermatous GvHD 15 samples shares therapies
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.